Advertisement
Organisation › Details
Alizé Pharma III S.A.S. (Alizé Pharma 3)
Alizé Pharma 3 develops innovative therapeutic peptides for rare endocrine and metabolic diseases. Its ambition is to become a leading company in rare diseases with operations in both Europe and the US to support the global development of products. Alizé Pharma 3 is building an innovative and balanced portfolio of products targeting significant unmet medical needs. Its first two assets are AZP3601, a PTH analog for hypoparathyroidism, and AZP-3404, a peptide leveraging the biology of IGFBP2 for treating syndromes of severe insulin resistance. *
Start | 2014-12-01 established | |
End | 2020-06-02 renamed | |
Group | AstraZeneca (Group) | |
Today | Amolyt Pharma S.A.S. | |
Successor | Amolyt Pharma S.A.S. | |
Industry | peptide-based drug | |
Person | Abribat, Thierry (Alizé Pharma 2007– President + Founder) | |
Region | Lyon | |
Country | France | |
Street | 15 chemin du Saquin Espace Européen, Building G | |
City | 69130 Ecully | |
Tel | +33-4-7218-9428 | |
Address record changed: 2022-10-10 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Alizé Pharma. (7/31/19). "Press Release: Alizé Pharma 3 Raises €67 million ($75 million) in Series A from a Strong International Syndicate". Lyon. | ||
Record changed: 2024-03-20 |
Advertisement
More documents for AstraZeneca (Group)
- [1] Amolyt Pharma S.A.S.. (3/14/24). "Press Release: Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca. AstraZeneca Will Acquire Amolyt Pharma for up to $1.05 Billion in Total Consideration". Lyon & Cambridge, MA....
- [2] Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)"....
- [3] SandboxAQ. (6/22/23). "Press Release: SandboxAQ Announces Biopharma Molecular Simulation Division to Speed Life-Saving Drugs to Patients Through AI and Quantum Solutions". Palo Alto, CA....
- [4] Transgene S.A.. (5/5/23). "Press Release: Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio". Strasbourg....
- [5] AstraZeneca plc. (1/9/23). "Press Release: AstraZeneca to Acquire CinCor Pharma to Strengthen Cardiorenal Pipeline"....
- [6] Amolyt Pharma S.A.S.. (1/6/23). "Press Release: Amolyt Pharma Announces $138 Million Series C Financing led by Sofinnova Partners and co-led by Intermediate Capital Group". Lyon & Cambridge, MA....
- [7] RQ Biotechnology Ltd.. (5/17/22). "Press Release: RQ Bio Launches with Goal to Transform Treatment and Prevention of Viral Infectious Diseases Through Antibody Technologies". London....
- [8] Amolyt Pharma S.A.S.. (2/4/22). "Press Release: Amolyt Pharma Selected for the French Tech 120 Program". Lyon & Cambridge, MA....
- [9] CinCor Pharma, Inc.. (10/12/21). "Press Release: CinCor Pharma Raises $143 Million in Series B Financing". Cincinnati, OH....
- [10] Amolyt Pharma S.A.S.. (9/16/21). "Press Release: Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners". Lyon & Cambridge, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top